investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Gladius Capital's Q3 and Q4 2022: A Tale of Significant Holding Changes

Ava Hoppe | 23 April, 2023

Gladius Capital Management LP is making headlines with its Q3 and Q4 2022 comparison of 13F holdings. This quarter has seen buying, selling, and options trades from the fund across different sectors. In this blog post, we will analyze the changes in the holdings of Gladius Capital Management LP by taking a closer look at the top holdings that have seen a significant change in the number of shares and change percentage.

UnitedHealth Group Inc.

UnitedHealth Group Inc. has proven to be a favorable pick for Gladius Capital Management LP. The fund bought 167,000 shares in the Q3, which jumped to 455,500 shares in Q4. The value of shares owned in UnitedHealth Group Inc. also rose from $84,342,000 to $241,497,000. This indicates that the fund is bullish on the company's prospects in Q4.

Invesco QQQ TR

The story for Invesco QQQ TR is different as Gladius Capital Management LP had a large call option of 1,120,000 shares in Q3. However, this quarter saw the fund sell 600,000 shares, reducing its shareholdings to 600,000. This translated to the value of the shares decreasing from $299,332,000 to $159,768,000, a significant dip of 46.6%.

Apple Inc.

Apple Inc. has been a mixed bag for Gladius Capital Management LP in the Q3 and Q4 comparison of holdings. The fund had a large put option of 1,333,400 shares in Q3, which was reduced to 681,200 shares in Q4. This indicates that the fund is not as confident about Apple Inc.'s prospects as it was in the previous quarter. Also, the value of the shares decreased from $184,276,000 to $88,509,000, a dip of 52%.

Walmart Inc.

Walmart Inc. is one of the top holdings for Gladius Capital Management LP that has seen a significant surge in the number of shares held. The fund had only 19,100 shares in Q3. However, it increased its shareholdings to 608,500 shares in Q4. This led to a significant increase in the value of shares owned from $2,478,000 to $86,280,000, a massive increase of 3,381.8%.

Overall, Gladius Capital Management LP's Q3 and Q4 2022 comparison of 13F holdings show that the fund made a significant number of changes in its portfolio. The fund seemed to be bullish on some of its top holdings, such as UnitedHealth Group Inc. and Walmart Inc., while reducing its stakes in others, such as Invesco QQQ TR and Apple Inc.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.